Trials / Recruiting
RecruitingNCT06978426
Hand-Held Dynamometer Assessment: E-Sports Grip-Asymmetry Index as a Predictor of Wrist Pain
Evaluation of Grip Strength Asymmetry Index in Professional E-Sports Athletes as a Predictive Measure for Wrist Pain
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 56 (estimated)
- Sponsor
- Ahram Canadian University · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
This cross-sectional study investigates whether a simple Grip-Asymmetry Index (GAI) can predict self-reported wrist pain in professional e-sports athletes. Professional gamers (aged 18-30) who play at least 35 hours per week will be assessed using a Jamar dynamometer to measure maximal grip force in both hands. The study will compare GAI between two groups: those with wrist pain (≥3/10 on Visual Analog Scale during play) and those without pain. A GAI cutoff value for predicting wrist pain risk will be established through ROC analysis, with additional factors such as gaming hours, BMI, and sex incorporated into a multivariable logistic regression model.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pain Group | Professional e-sports athletes who report wrist pain rated at 3 or higher on a 10-point Visual Analog Scale during gaming activities. These participants play video games professionally for at least 35 hours per week, are between 18-30 years old, and have no history of neurologic or rheumatic disease. |
| OTHER | No-Pain Group | Professional e-sports athletes who report minimal to no wrist pain (less than 3 on a 10-point Visual Analog Scale) during gaming activities. These participants play video games professionally for at least 35 hours per week, are between 18-30 years old, and have no history of neurologic or rheumatic disease. |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2025-05-18
- Last updated
- 2025-05-18
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06978426. Inclusion in this directory is not an endorsement.